Paolani, G.; Minosse, S.; Strolin, S.; Santoro, M.; Pucci, N.; Di Giuliano, F.; Garaci, F.; Oddo, L.; Toumia, Y.; Guida, E.;
et al. Intra-Arterial Super-Selective Delivery of Yttrium-90 for the Treatment of Recurrent Glioblastoma: In Silico Proof of Concept with Feasibility and Safety Analysis. Pharmaceutics 2025, 17, 345.
https://doi.org/10.3390/pharmaceutics17030345
AMA Style
Paolani G, Minosse S, Strolin S, Santoro M, Pucci N, Di Giuliano F, Garaci F, Oddo L, Toumia Y, Guida E,
et al. Intra-Arterial Super-Selective Delivery of Yttrium-90 for the Treatment of Recurrent Glioblastoma: In Silico Proof of Concept with Feasibility and Safety Analysis. Pharmaceutics. 2025; 17(3):345.
https://doi.org/10.3390/pharmaceutics17030345
Chicago/Turabian Style
Paolani, Giulia, Silvia Minosse, Silvia Strolin, Miriam Santoro, Noemi Pucci, Francesca Di Giuliano, Francesco Garaci, Letizia Oddo, Yosra Toumia, Eugenia Guida,
and et al. 2025. "Intra-Arterial Super-Selective Delivery of Yttrium-90 for the Treatment of Recurrent Glioblastoma: In Silico Proof of Concept with Feasibility and Safety Analysis" Pharmaceutics 17, no. 3: 345.
https://doi.org/10.3390/pharmaceutics17030345
APA Style
Paolani, G., Minosse, S., Strolin, S., Santoro, M., Pucci, N., Di Giuliano, F., Garaci, F., Oddo, L., Toumia, Y., Guida, E., Riccitelli, F., Perilli, G., Vitaliti, A., Bedini, A., Dolci, S., Paradossi, G., Domenici, F., Da Ros, V., & Strigari, L.
(2025). Intra-Arterial Super-Selective Delivery of Yttrium-90 for the Treatment of Recurrent Glioblastoma: In Silico Proof of Concept with Feasibility and Safety Analysis. Pharmaceutics, 17(3), 345.
https://doi.org/10.3390/pharmaceutics17030345
